News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Oncotarget | The chromatographic constitution of andiroba oil and its healing effects…

News

January 24, 2023
PRESS RELEASE: On January 12, 2023, Oncotarget published a new research paper: “The chromatographic constitution of andiroba oil and its healing effects, compared to the LLLT outcomes, in oral mucositis induced in golden Syrian hamsters: a new treatment option.” continue reading »

Oncoscience | A murine model for human early/immature T-cell precursor acute lymphoblastic leukemia (EITP ALL)

News

January 23, 2023
PRESS RELEASE: On October 24, 2022, a new research perspective was published in Oncoscience, entitled, “A murine model for human early/immature T-cell precursor acute lymphoblastic leukemia (EITP ALL).” continue reading »

Aging | Genetic deficiency and pharmacological modulation of ROR alpha regulate laser-induced choroidal neovascularization

Aging

January 18, 2023
PRESS RELEASE: A new research paper was published in Aging's Volume 15, Issue 1, entitled, “Genetic deficiency and pharmacological modulation of RORα regulate laser-induced choroidal neovascularization.” continue reading »

Oncotarget | Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001

News

January 17, 2023
PRESS RELEASE: On January 12, 2023, Oncotarget published a new research paper, entitled, “Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001.” continue reading »

Oncoscience | Association between tumor mutations and meningioma recurrence in Grade I/II disease

News

January 17, 2023
PRESS RELEASE: On December 9, 2022, a new research paper was published in Oncoscience, entitled, “Association between tumor mutations and meningioma recurrence in Grade I/II disease.” continue reading »